Skip to content

NuSkin Enterprises NUS Change in Accrued Liabilities

Change in Accrued Liabilities at other companies

Nature's Sunshine Products logo
Nature's Sunshine ProductsNATR
-$8.74M-683%
Lifevantage Corporation logo
Lifevantage CorporationLFVN
-$396K-109%
Solesence, Inc. Common Stock logo
Solesence, Inc. Common StockSLSN
-$367K-188%
Kenvue logo
KenvueKVUE
$5M+66.7%
Celsius Holdings, Inc. logo
Celsius Holdings, Inc.CELH
$38.95M+549%
electroCore, Inc. logo
electroCore, Inc.ECOR
$1.4M+206%

Other financials

Income statement

See full
Revenue$320.6M-12.0%
Gross profit$214.5M-13.2%
Operating income$4.0M+141%
Net income$1.8M-98.3%
EPS (diluted)$0.04-98.1%

Balance sheet

See full
Cash & equivalents$198.7M-2.5%
Total debt$303.6M-8.2%
Total equity$794.1M+5.3%
Total assets$1.4B-1.1%

Cash flow

See full
Operating cash flow-$3.9M-1,107%
CapEx$13.7M+1.0%
Free cash flow-$17.6M-33.6%

Valuation

See full
Market cap$256.35M-34.9%

Where this comes from

Reported directly by NuSkin Enterprises in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilities.

The official record: NuSkin Enterprises’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about NuSkin Enterprises's change in accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NuSkin Enterprises's change in accrued liabilities?
NuSkin Enterprises (NUS) reported change in accrued liabilities of -$14.7M in Q1 2026.
How has NuSkin Enterprises's change in accrued liabilities changed year-over-year?
NuSkin Enterprises's change in accrued liabilities increased by 30.1% year-over-year, from -$21.02M to -$14.7M.
What is the long-term trend for NuSkin Enterprises's change in accrued liabilities?
Over 3 years (2021 to 2025), NuSkin Enterprises's change in accrued liabilities has grown at a -19.4% compound annual growth rate (CAGR), from -$104.99M to -$55M.
What does change in accrued liabilities mean?
Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.